BACKGROUND: A promising approach to treat diabetes is the development of an automated bihormonal pump administering glucagon and insulin. A physically and chemically stable glucagon formulation does not currently exist. Our goal is to develop a glucagon formulation that is stable as a clear ungelled solution, free of fibrils at a pH of 7 for at least 7 days at 37 °C. METHODS: Experimental glucagon formulations were studied for stability at 25 and 37 °C. Chemical degradation was quantified by reverse phase ultra-performance liquid chromatography. Physical changes were studied using light obscuration and visual observations. RESULTS: Glucagon content of Biodel glucagon and Lilly glucagon at pH 2 and pH 4, as measured by high-performance liquid chromatography at 25 °C, was 100% at 7 days compared to 87% and <7%, respectively. Light obscuration measurements indicated Lilly glucagon at pH 4 formed an opaque gel, while Biodel glucagon formulation remained a clear solution beyond 50 days at 37 °C. Visual observations confirmed these results. CONCLUSIONS: Biodel glucagon is a stabilized formulation at physiological pH and remains chemically and physically stable beyond 7 days at 37 °C, suggesting its utility for use in a bihormonal pump.
BACKGROUND: A promising approach to treat diabetes is the development of an automated bihormonal pump administering glucagon and insulin. A physically and chemically stable glucagon formulation does not currently exist. Our goal is to develop a glucagon formulation that is stable as a clear ungelled solution, free of fibrils at a pH of 7 for at least 7 days at 37 °C. METHODS: Experimental glucagon formulations were studied for stability at 25 and 37 °C. Chemical degradation was quantified by reverse phase ultra-performance liquid chromatography. Physical changes were studied using light obscuration and visual observations. RESULTS:Glucagon content of Biodel glucagon and Lilly glucagon at pH 2 and pH 4, as measured by high-performance liquid chromatography at 25 °C, was 100% at 7 days compared to 87% and <7%, respectively. Light obscuration measurements indicated Lilly glucagon at pH 4 formed an opaque gel, while Biodel glucagon formulation remained a clear solution beyond 50 days at 37 °C. Visual observations confirmed these results. CONCLUSIONS: Biodel glucagon is a stabilized formulation at physiological pH and remains chemically and physically stable beyond 7 days at 37 °C, suggesting its utility for use in a bihormonal pump.
Authors: Arleen Pinkos; Guillermo Arreaza-Rubin; William J Heetderks; Ilan Irony; Hylton V Joffe; Bruce Schneider; Charles L Zimliki Journal: Drug Discov Today Technol Date: 2007
Authors: Firas H El-Khatib; Steven J Russell; David M Nathan; Robert G Sutherlin; Edward R Damiano Journal: Sci Transl Med Date: 2010-04-14 Impact factor: 17.956
Authors: Richard Mauseth; Youqing Wang; Eyal Dassau; Robert Kircher; Donald Matheson; Howard Zisser; Lois Jovanovic; Francis J Doyle Journal: J Diabetes Sci Technol Date: 2010-07-01
Authors: Melanie A Jackson; Nicholas Caputo; Jessica R Castle; Larry L David; Charles T Roberts; W Kenneth Ward Journal: Curr Diab Rep Date: 2012-12 Impact factor: 4.810
Authors: Nicholas Caputo; Jessica R Castle; Colin P Bergstrom; Julie M Carroll; Parkash A Bakhtiani; Melanie A Jackson; Charles T Roberts; Larry L David; W Kenneth Ward Journal: Peptides Date: 2013-05-04 Impact factor: 3.750
Authors: Nicholas Caputo; Melanie A Jackson; Jessica R Castle; Joseph El Youssef; Parkash A Bakhtiani; Colin P Bergstrom; Julie M Carroll; Matthew E Breen; Gerald L Leonard; Larry L David; Charles T Roberts; W Kenneth Ward Journal: Diabetes Technol Ther Date: 2014-06-26 Impact factor: 6.118
Authors: Zejun Wang; Jinqiang Wang; Hongjun Li; Jicheng Yu; Guojun Chen; Anna R Kahkoska; Valerie Wu; Yi Zeng; Di Wen; Jayson R Miedema; John B Buse; Zhen Gu Journal: Proc Natl Acad Sci U S A Date: 2020-11-11 Impact factor: 11.205